Users commonly report improved skin texture, reduced fine lines, and faster recovery from tissue damage
Gonzlez F, Considine RV, Abdelhadi OA, Acton AJ
Wright, John W, and Joseph W Harding
Effective compounding-based GLP-1 treatment requires ongoing provider communication about side effects, injection technique, nutritional intake, and dose titration schedules
Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine beta-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer
Episodes of vomiting are most common during the initiation phase and following dose increases, with frequency and severity typically decreasing over time